Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.

Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines.

CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer. We’ve all heard such blusterous aspirational hype before, to be sure ...

Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 hours.

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

Larry Ellison of Oracle and also included Microsoft, NVIDIA and more. "A new American company that will invest $500 billion, at least, in AI infrastructure in the United States, creating over ...

Moderna shares are rising after Oracle’s Larry Ellison highlights AI’s role in ... and sequence cancer genes to create personalized mRNA vaccines. He claimed AI-driven automation could enable ...

At the launch of Stargate Project, Oracle's Ellison said that AI could assist in identifying the cancer fragments early ...

Oracle founder Larry Ellison said the massive artificial intelligence ... "And you can make that vaccine, that mRNA vaccine, you can make that robotically again using AI in about 48 hours." ...

Oracle Chairman Larry Ellison highlighted the potential medical benefits of the investment, stating that AI could be used to detect cancers and customize mRNA vaccines to treat them within 48 hours.

Even so, Mr Ellison remains the world’s fifth-richest man, and Oracle the third-biggest software firm. He has a thing or two ...